MSKCC DCIS Nomogram — Official Tool Guide
Clinical scope and interpretation of the official MSKCC DCIS Nomogram.
Purpose and scope
Generate estimates at the official MSKCC DCIS Nomogram. The original model was reported by Rudloff and colleagues in 2010 for ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.
The supported endpoint is recurrence in the same breast as either DCIS or invasive cancer at 5 and 10 years. It is not distant recurrence, breast-cancer survival, or treatment benefit.
External validation shows that calibration can differ between cohorts. Interpret the estimate within its source population, current pathology, competing risks, patient preferences, and multidisciplinary treatment context.
Sources
- Official MSKCC DCIS Nomogram
- Rudloff U, et al. J Clin Oncol. 2010;28:3762-3769. PMID 20625132.
- External validation, PMID 37190320.
Related references
This page is a clinical reference to the official tool, not an independent implementation or prospective validation.